Kendall Law Group Investigates Clarient, Inc. Acquisition for Shareholders
22 Outubro 2010 - 11:41AM
Business Wire
Kendall Law Group, led by former federal judge Joe Kendall, is
investigating Clarient, Inc. (NASDAQ: CLRT) for shareholders in
connection with the proposed acquisition of the company by GE
Healthcare. The national securities firm’s investigation seeks to
determine whether Clarient and its Board breached their fiduciary
duties by entering into the agreement without properly shopping for
a deal that would provide better value for shareholders. If you are
a Clarient shareholder and would like additional information about
your rights, contact the Kendall Law Group at 877-744-3728 or by
email at skendall@kendalllawgroup.com.
On October 22, 2010, the companies announced the definitive
merger agreement under which Clarient would be acquired by GE
Healthcare in a transaction valued at approximately $580 million.
Under the terms of the agreement, Clarient stockholders will
receive $5.00 in cash for each share of Clarient/CLRT common stock
held. According to Thompson/First Call, at least one analyst has
set a price target of $6.00 per share for Clarient stock. The firm
believes the transaction may be undervaluing the company.
Kendall Law Group was founded by a former federal judge,
includes a former United States Attorney, prosecutors and
securities lawyers who are experienced in complex securities
litigation. The firm has been counsel in numerous merger and
acquisition cases nationwide, including some of the largest
transactions in the United States.
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Clarient, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Kendall Law Group